The next board meeting for CytomX Therapeutics Inc is on 10 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference 2025See details
CytomX Therapeutics Inc has a share price target of US$ 6, revenue growth forecast of -32.1%, and profit growth estimate of -75.5% for FY25, based on top 7 analyst calls.